<code id='7EF18A9397'></code><style id='7EF18A9397'></style>
    • <acronym id='7EF18A9397'></acronym>
      <center id='7EF18A9397'><center id='7EF18A9397'><tfoot id='7EF18A9397'></tfoot></center><abbr id='7EF18A9397'><dir id='7EF18A9397'><tfoot id='7EF18A9397'></tfoot><noframes id='7EF18A9397'>

    • <optgroup id='7EF18A9397'><strike id='7EF18A9397'><sup id='7EF18A9397'></sup></strike><code id='7EF18A9397'></code></optgroup>
        1. <b id='7EF18A9397'><label id='7EF18A9397'><select id='7EF18A9397'><dt id='7EF18A9397'><span id='7EF18A9397'></span></dt></select></label></b><u id='7EF18A9397'></u>
          <i id='7EF18A9397'><strike id='7EF18A9397'><tt id='7EF18A9397'><pre id='7EF18A9397'></pre></tt></strike></i>

          Wikipedia

          Wikipedia

          author:hotspot    Page View:888
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical leaders decry Supreme Court decision on affirmative action
          Medical leaders decry Supreme Court decision on affirmative action

          STEFANIREYNOLDS/AFPviaGettyImagesMedicalleadersonThursdayreactedswiftlytotheSupremeCourt’sdecisionto

          read more
          Congress might make insulin pumps more accessible to the blind
          Congress might make insulin pumps more accessible to the blind

          AdobeKatieKeimwasdiagnosedwithtype1diabetesin1967whenshewaseight,wellbeforetheeraofinsulinpumpsoreve

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Medicaid, Medicare dual

          TheSenatehassetitseyesonregulatinginsuranceplansforsomeofthemostvulnerablepatientsintheU.S.— the12.5